ValueAct Thesis On Willis Group

ValueAct got his “win” at Willis Group this week, with the merger with Towers Watson. It was a relatively untold story of Willis Group, but maybe for good reason. Since Jeff Ubben profiled Willis Group at the 2013 VIC conference, shares are up just 9%.

Here was Ubben’s key thesis from VIC:

h/t Ben Levisohn

This Tiger Cub Giant Is Betting On Banks And Tech Stocks In The Recovery

D1 CapitalThe first two months of the third quarter were the best months for D1 Capital Partners' public portfolio since inception, that's according to a copy of the firm's August update, which ValueWalk has been able to review. Q2 2020 hedge fund letters, conferences and more According to the update, D1's public portfolio returned 20.1% gross Read More

h/t @ldelevingne

Even though it wasn’t the home run since 2013, ValueAct made out fairly well. Since it went active in 2010, the stock is up 54%.

And yet, a 9.3% annualized return might not be all that great – compared to the S&P 500 annualized 14.8% over that same period.